Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jun;187(6):344-9.
doi: 10.1007/s00066-011-2197-7. Epub 2011 May 16.

Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity

Affiliations
Clinical Trial

Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity

Arne Gruen et al. Strahlenther Onkol. 2011 Jun.

Abstract

Purpose: Compared to laparotomic surgery, laparoscopically assisted radical vaginal hysterectomy (LARVH) offers decreased blood loss during surgery and faster convalescence of the patient postoperatively, while at the same time delivering similar oncologic results. However, there is no data on outcome and toxicity of LARVH followed by (chemo)radiation.

Patients and methods: A total of 55 patients (range 28-78 years) with cervical cancer on FIGO stages IB1-IIIA (Tables 1 and 2) with risk factors were submitted to either external beam radiotherapy alone [EBRT, n = 8 (14%), including paraaortic irradiation, n = 4 (2.2%); EBRT and brachytherapy (BT), n = 33 (60%); BT alone, n = 14 (25.5%)] or chemoradiation after LARVH.

Results: At a median follow-up of 4.4 years, the 5-year disease-free survival (DFS) was 81.8% with 84.5% overall survival (OS). Acute grade 3 side effects were seen in 4 patients. These were mainly gastrointestinal (GI) and genitourinary (GU) symptoms. Grade 4 side effects were not observed.

Conclusion: With similar oncologic outcome data and mostly mild side effects, LARVH followed by (chemo)radiation is a valid alternative in the treatment of cervical cancer patients.

PubMed Disclaimer

References

    1. Gynecol Oncol. 2003 Oct;91(1):139-48 - PubMed
    1. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):982-7 - PubMed
    1. Gynecol Oncol. 2004 Oct;95(1):52-61 - PubMed
    1. J Clin Oncol. 2000 Apr;18(8):1606-13 - PubMed
    1. Int J Gynecol Cancer. 2000 Jan;10(1):59-66 - PubMed

Publication types

MeSH terms

Substances